Which ancillary properties of beta-adrenoceptor blocking drugs influence their therapeutic or adverse effects?: a review.
Department of Clinical Pharmacology, St Bartholomew's Hospital, London.
P
P
Turner
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans
D000319:Adrenergic beta-Antagonists